STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
The failure of an experimental drug for Angelman syndrome, a rare genetic disease that causes severe developmental delays, was a major blow to patients and the drug’s maker, Ultragenyx, which announced the outcome of its late-stage trial earlier this week.…
But experts cautioned that there is still reason to think similar expe…
That could potentially pave the way for genetic medicines in other neu…
“I don’t think this really says anything about the other trials that a…
Frontier AI faces pricing reckoning as token volume explodes 25-fold — mid-tier models deliver 90% of flagship capability at one-sixth the cost
AI development might not be the wild west it was when ChatGPT burst onto the scene a few years ago, but it's still very much a frontier, with no clear boundaries and few yardsticks.…
But for AI developers on the frontier, they're pulling hard towards du…
Although Anthropic's Claude Fable and Opus models have been consistent…
For more general use, some are paying closer attention to the "Pareto …
Ocean Carriers Reroute as Panama Canal, Asian Port Congestion Crater Schedule Reliability
Container vessel schedule reliability fell to 56.4 percent in July, a 6.1-percentage-point decline from June and the sharpest single-month deterioration since January 2021.
Retail, Supply Chain Groups Urge Inclusion of Federal Organized Retail Crime Bill in Defense Spending Package
Groups like the National Retail Federation, the World Shipping Council and the American Trucking Association are lobbying lawmakers to prioritize the Combating Organized Retail Crime Act.